131 results
Page 2 of 7
8-K
3819cu87c 472ttjuxu1
21 Jun 21
Departure of Directors or Certain Officers
4:05pm
424B5
rwmug 8og6
5 May 21
Prospectus supplement for primary offering
4:01pm
DEFA14A
zmhbhia7j993u
26 Apr 21
Additional proxy soliciting materials
4:35pm
424B5
n8o5cky5n 9ilg2
27 Aug 20
Prospectus supplement for primary offering
5:24pm
424B5
r8cx 9em8u
26 Aug 20
Prospectus supplement for primary offering
5:30pm
8-K
EX-1.1
qft fg927w79qqufaio
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
424B5
fjho pgbjsx8lw4drvcr
1 Jul 20
Prospectus supplement for primary offering
4:49pm
8-K
7pf9l7i5d2qgj
26 Jun 20
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.1
9umgr ufpaqyi
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
424B5
k0f jx5qptra
10 Mar 20
Prospectus supplement for primary offering
3:04pm